METHODS AND COMPOSITIONS FOR TREATING RETINA-ASSOCIATED DISEASE USING CCR3-INHIBITORS

Methods of improving visual endpoints related to retina-associated disease with CCR3 modulating agents are provided. An example of such an endpoint is visual acuity. Retina-associated diseases upon which visual acuity and other visual endpoints may be improved include retinopathy of prematurity, age...

Full description

Saved in:
Bibliographic Details
Main Authors NIKOLICH, Karoly, JACKSON, Sam, CORADINI, Laura
Format Patent
LanguageEnglish
French
German
Published 12.02.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Methods of improving visual endpoints related to retina-associated disease with CCR3 modulating agents are provided. An example of such an endpoint is visual acuity. Retina-associated diseases upon which visual acuity and other visual endpoints may be improved include retinopathy of prematurity, age-related macular degeneration, central retinal vein occlusion, and diabetic retinopathy.
Bibliography:Application Number: EP20180720836